ATE21900T1 - Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen. - Google Patents

Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.

Info

Publication number
ATE21900T1
ATE21900T1 AT82303311T AT82303311T ATE21900T1 AT E21900 T1 ATE21900 T1 AT E21900T1 AT 82303311 T AT82303311 T AT 82303311T AT 82303311 T AT82303311 T AT 82303311T AT E21900 T1 ATE21900 T1 AT E21900T1
Authority
AT
Austria
Prior art keywords
pyridyl
sub
oxo
sup
dimethyl
Prior art date
Application number
AT82303311T
Other languages
English (en)
Inventor
George Sidney Sach
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of ATE21900T1 publication Critical patent/ATE21900T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
AT82303311T 1981-06-27 1982-06-25 Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen. ATE21900T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8119906 1981-06-27
EP82303311A EP0068834B1 (de) 1981-06-27 1982-06-25 Pyrimidinonderivate und diese enthaltende pharmazeutische Zusammenstellungen

Publications (1)

Publication Number Publication Date
ATE21900T1 true ATE21900T1 (de) 1986-09-15

Family

ID=10522859

Family Applications (2)

Application Number Title Priority Date Filing Date
AT82303311T ATE21900T1 (de) 1981-06-27 1982-06-25 Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.
AT82303310T ATE22891T1 (de) 1981-06-27 1982-06-25 Pyrimidinonderivate und diese enthaltende pharmazeutische zusammensetzungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT82303310T ATE22891T1 (de) 1981-06-27 1982-06-25 Pyrimidinonderivate und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (27)

Country Link
US (4) US4486434A (de)
EP (2) EP0068834B1 (de)
JP (4) JPS588079A (de)
KR (1) KR880001475B1 (de)
AT (2) ATE21900T1 (de)
AU (2) AU8535282A (de)
BG (1) BG38163A3 (de)
CS (1) CS241036B2 (de)
DD (1) DD202291A5 (de)
DE (2) DE3273019D1 (de)
DK (2) DK287082A (de)
ES (1) ES8305755A1 (de)
FI (1) FI822281L (de)
GR (2) GR74926B (de)
HU (1) HU190396B (de)
IE (1) IE53348B1 (de)
IL (1) IL66125A (de)
JO (1) JO1185B1 (de)
NO (1) NO822120L (de)
NZ (1) NZ201077A (de)
PH (1) PH19680A (de)
PL (3) PL137600B1 (de)
PT (1) PT75074B (de)
SU (1) SU1232145A3 (de)
YU (1) YU138982A (de)
ZA (2) ZA824537B (de)
ZW (1) ZW13082A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
DE3376422D1 (en) * 1982-03-25 1988-06-01 Smith Kline French Lab Process for preparing 3,5-disubstituted 2-pyridylalkyl amines
GR78463B (de) * 1982-03-25 1984-09-27 Smith Kline French Lab
PT77287B (en) * 1982-10-01 1986-02-04 Smith Kline French Lab Compound
GB8319874D0 (en) * 1983-07-23 1983-08-24 Smith Kline French Lab Compounds
CA1286297C (en) * 1985-06-13 1991-07-16 George S. Sach Pyridine derivatives
GB8601816D0 (en) * 1986-01-25 1986-02-26 Smith Kline French Lab Pyridine derivatives
GB8610867D0 (en) * 1986-05-02 1986-06-11 Smith Kline French Lab 3-hydroxypyridines
JP2679977B2 (ja) * 1986-09-19 1997-11-19 株式会社日立製作所 半導体集積回路
WO1989010124A1 (en) * 1988-04-27 1989-11-02 Kievsky Nauchno-Issledovatelsky Institut Farmakolo Antidote for organic phosphorus compound poisoning
US5216170A (en) * 1989-01-26 1993-06-01 Bayer Aktiengesellschaft (2-aminopropyl) pyridines useful as intermediates
KR100498005B1 (ko) * 2002-07-26 2005-07-01 주식회사 소하드 기능성 액상비료 및 그 제조방법
AU2003297458A1 (en) * 2002-12-20 2004-07-22 Exxonmobil Chemical Patents Inc. Polymerization processes
US7443103B2 (en) * 2005-06-24 2008-10-28 General Electric Company High pressure lamp with lamp flicker suppression and lamp voltage control
MX2011000390A (es) * 2008-07-10 2011-03-01 Novartis Ag Sulfonas ciclicas con sustitucion de amino-bencilo utiles coimo inhibidores de bace.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN146736B (de) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4227000A (en) * 1978-04-11 1980-10-07 Smith Kline & French Laboratories Limited Intermediates in the process for making histamine antagonists
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
US4255428A (en) * 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
EP0017680B1 (de) * 1979-04-11 1982-04-21 Smith Kline & French Laboratories Limited Pyrimidon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative

Also Published As

Publication number Publication date
FI822281L (fi) 1982-12-28
JPS61233670A (ja) 1986-10-17
JPH0244812B2 (de) 1990-10-05
ZW13082A1 (en) 1982-09-29
ZA824580B (en) 1983-05-25
JPS6328424B2 (de) 1988-06-08
PT75074A (en) 1982-07-01
DE3273019D1 (en) 1986-10-09
EP0068833A3 (en) 1983-03-30
JPH0345073B2 (de) 1991-07-09
EP0068833A2 (de) 1983-01-05
ATE22891T1 (de) 1986-11-15
NO822120L (no) 1982-12-28
GR74925B (de) 1984-07-12
JPS61233616A (ja) 1986-10-17
SU1232145A3 (ru) 1986-05-15
JO1185B1 (en) 1983-11-30
EP0068834A2 (de) 1983-01-05
KR840000533A (ko) 1984-02-25
JPS588079A (ja) 1983-01-18
HU190396B (en) 1986-08-28
PL137627B1 (en) 1986-07-31
AU8535182A (en) 1983-01-06
ES513469A0 (es) 1983-05-01
DK286982A (da) 1982-12-28
AU8535282A (en) 1983-01-06
GR74926B (de) 1984-07-12
IL66125A0 (en) 1982-09-30
IL66125A (en) 1986-01-31
PH19680A (en) 1986-06-13
US4444772A (en) 1984-04-24
US4584381A (en) 1986-04-22
CS480082A2 (en) 1985-06-13
ES8305755A1 (es) 1983-05-01
YU138982A (en) 1985-03-20
NZ201077A (en) 1985-09-13
PL138524B1 (en) 1986-09-30
IE53348B1 (en) 1988-10-26
US4535163A (en) 1985-08-13
BG38163A3 (en) 1985-10-15
PL137600B1 (en) 1986-07-31
DE3273782D1 (en) 1986-11-20
PT75074B (en) 1986-02-26
DD202291A5 (de) 1983-09-07
EP0068834B1 (de) 1986-09-03
EP0068834A3 (en) 1983-04-06
FI822281A0 (fi) 1982-06-24
EP0068833B1 (de) 1986-10-15
DK287082A (da) 1982-12-28
JPS588080A (ja) 1983-01-18
ZA824537B (en) 1983-05-25
AU551066B2 (en) 1986-04-17
PL237110A1 (en) 1983-06-20
PL240628A1 (en) 1983-10-10
KR880001475B1 (ko) 1988-08-13
US4486434A (en) 1984-12-04
IE821533L (en) 1982-12-27
CS241036B2 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
ATE21900T1 (de) Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.
FI931600A0 (fi) Pyridiner och pyridin-n-oxidderivat av diarylmetylpiperidiner eller piperaziner, och foereningar och foerfarande foer deras anvaendning
YU69991A (sh) Derivati piridina
FR2667068B1 (fr) Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE27818T1 (de) Pyrimidonderivate.
IL83088A0 (en) Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them
DK84785D0 (da) Kinatsalte af antimalariaforbindelsen mefloquin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee